Based on our study, we proposed that the rimonabant intervention on early obesity of ApoE*3Leiden.CETP mice would affect plasma and hepatic lipid metabolism relative to the non-treated controls, leading to increased HDL-C concentrations and decreased VLDL/LDL-C levels. This evidence concerns the gene APOE and Obesity.